Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @_bakulpatel: Smart Regulations! A quest to create a more efficient, effective and a learning regulatory paradigm for advancing… https://t.co/MVKpF1kNGD
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_Track: FDA pledges 'efficient regulation' of mobile #healthapps https://t.co/Y0UA437yoe via @healthcaredive
SteveFDA (R-D.C.)
@SGottliebFDA
From #FDAOncology a #NEJM Perspective describes use of metastasis-free survival as a new potential endpoint for prostate cancer clinical trials https://t.co/UpkI07rJVB
SteveFDA (R-D.C.)
@SGottliebFDA
My note today to my #FDA colleagues about the landmark law that laid the foundation for FDA’s modern framework for protecting and promoting American health. https://t.co/s8OQ3y58mE https://t.co/8cQJYJjk9c
SteveFDA (R-D.C.)
@SGottliebFDA
RT @Cardiology: From @JAMA_current: FDA Regulation of Mobile Medical Apps https://t.co/GA9dyqqDew @_bakulpatel @SGottliebFDA https://t.co/9N0JAgZyka
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: The FDA is holding a public meeting to discuss our Nutrition Innovation Strategy. Join the national conversation on… https://t.co/fHltkpwAxU
SteveFDA (R-D.C.)
@SGottliebFDA
Today @CDCgov reported 27 new Cyclospora illnesses linked to recalled Del Monte vegetable trays sold in IA, IN, MI, MN, WI. #FDA is investigating each component of these vegetable trays, how they became contaminated, and will continue to provide updates https://t.co/u4h9daqeG0
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAMedia: FDA Commissioner @SGottliebFDA talks about the landmark law that laid the foundation for FDA’s modern framework for… https://t.co/TiMEuIrMpy
SteveFDA (R-D.C.)
@SGottliebFDA
Patient Reported Outcome measures to inform tolerability- #PRO experts, international regulators, @theNCI & patients discuss uses of PRO in cancer trials @CPathInstitute 2017 workshop summary https://t.co/hwWFS5ogbv #OCEOutcomes #OCEPFDD
SteveFDA (R-D.C.)
@SGottliebFDA
Drug labeling is the primary tool for communicating info on the drug to providers and patients, so #FDA must ensure labeling is informative and clear. Our draft guidance issued today will help health care providers identify treatments for their patients https://t.co/gEojx5U5lb
SteveFDA (R-D.C.)
@SGottliebFDA
RT @califf001: Solid plan from FDA on mobile apps. As it evolves i think FDA will show the right level of oversight with flexibility. @dukeforge FDA Regulation of Mobile Medical Apps https://t.co/BbJZiqv9jm
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAWomen: Did you know some types of medications can increase your risk of sunburn? It’s true! Learn more: https://t.co/70BG0xEIsA
SteveFDA (R-D.C.)
@SGottliebFDA
Looking for opioid use disorder treatment options in your state for yourself or a loved one? Please see @samhsagov’s Opioid Treatment Program Directory for important resources in your area: https://t.co/VSPKq2qWAN #stopMATstigma https://t.co/9cSMRzwJ9n
SteveFDA (R-D.C.)
@SGottliebFDA
Today’s revised #FDA guidance explains our determination that pooled blood donation testing can effectively reduce the risk of Zika Virus transmission: https://t.co/h62nrBytxe
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HlthExec: .@SGottliebFDA outlines #FDA approach to regulation of mobile apps in @JAMA_current viewpoint https://t.co/mmzCvqW393
SteveFDA (R-D.C.)
@SGottliebFDA
We will continue to monitor Zika closely & take action if needed. The latest evidence shows that pooled donations can effectively reduce transmission of Zika in blood. It is also usually more cost effective and less burdensome for blood establishments. https://t.co/h62nrBytxe
SteveFDA (R-D.C.)
@SGottliebFDA
Public health and patient safety at forefront of all our decisions. Today’s revised guidance explains the #FDA's latest determination that pooled testing of blood donations for Zika effectively reduces risk. https://t.co/BmQsLamS0O
SteveFDA (R-D.C.)
@SGottliebFDA
Following significant decrease in cases of Zika in US & territories, the #FDA announced today revised blood screening recommendations: https://t.co/h62nrBytxe
SteveFDA (R-D.C.)
@SGottliebFDA
SteveFDA (R-D.C.)
@SGottliebFDA
RT @theNCI: As a reminder, if you have questions about cancer or #clinicaltrials, the information specialists at NCI's Contact Center can help: https://t.co/Po56jx3UY9 1-800-4-CANCER #clinicaltrialssm https://t.co/GZoj1YLkhR